Subjective Outcome

Peptides for appetite

5 compoundsin Regimen’s catalog are configured to track appetite via Rate Today. Each one shows the dose range, listed benefits, and every outcome it’s set up to monitor. Tap through to plan a dose with the free reconstitution calculator.

5 compounds

Semaglutide

GLP-1 Receptor Agonist

GLP-1

A once-weekly GLP-1 receptor agonist for weight management and metabolic health.

  • Significant and sustained weight loss
  • Improved blood sugar regulation
  • Reduced cardiovascular risk markers

Tracks

WeightBMIAppetiteGlucose

Tirzepatide

GIP / GLP-1 Dual Agonist

GLP-1

A once-weekly dual GIP and GLP-1 receptor agonist delivering superior weight loss and metabolic improvements compared to GLP-1 monotherapy.

  • Greater average weight loss vs. semaglutide
  • Improved blood sugar control
  • Reduced appetite and cravings

Tracks

WeightBMIAppetiteGlucose

Liraglutide

GLP-1 Receptor Agonist (Saxenda / Victoza)

GLP-1

Daily injectable GLP-1 receptor agonist FDA-approved for type 2 diabetes (Victoza, up to 1.8 mg/day) and chronic weight management (Saxenda, up to 3.0 mg/day). Slows gastric emptying, increases satiety, improves glycemic control, and reduces cardiovascular events in T2D.

  • Sustained weight loss
  • A1C reduction in T2D
  • Appetite suppression and reduced food cravings

Tracks

WeightBMIAppetiteGlucose

Retatrutide

GIP / GLP-1 / Glucagon Triple Agonist

GLP-1

Tracks

WeightBMIAppetite

Cagrilintide

Long-Acting Amylin Analog

GLP-1

Tracks

WeightBMIAppetite

Other outcomes